Between presenting at the 39th Annual JP Morgan Healthcare Conference, acquiring an asset that boosted its precision oncology line, and presenting its preliminary fourth-quarter 2020 results, Exact Sciences had a busy week.
Five things Exact did this week:
1. Chair and CEO Kevin Conroy gave a series of updates Jan. 13 at the JP Morgan Healthcare Conference, Genome Web reported Jan. 14. Mr. Conroy said Exact tested more than 4 million people in 2020, contributing to the $1.49 billion in preliminary 2020 revenues the company reported Jan. 10.
2. Mr. Conroy reiterated Exact’s goal to be a leader in three diagnostic screening markets: colorectal cancer screening, multi-cancer screening, and minimal residual disease and recurrence monitoring. The three markets represent a combined $58 billion market.